Literature DB >> 223441

Tumorous phosphaturic osteomalacia. Report of a case associated with multiple hemangiomas of bone.

R A Daniels, I Weisenfeld.   

Abstract

A case of osteomalacia associated with hypophosphatemia, decreased tubular reabsorption of phosphorus, hyperphosphaturia and renal glycosuria with associated bone pain and myopathy is presented. The patient was found to have multiple osteolytic lesions of bone which, on biopsy, proved to be sclerosing hemangiomas of bone. Treatment with oral phosphate and vitamin D effected a diminution in his symptoms of bone pain and muscular weakness. The literature on hypophosphatemic phosphaturic osteomalacia associated with mesenchymal tumors is reviewed. It has been suggested that certain mesenchymal tumors elaborate a yet to be identified humoral substance which decreased synthesis of 1 alpha, 25-dihydroxycholecalciferol causing decreased tubular reabsorption of phosphorus, hyperphosphaturia, hypophosphatemic osteomalacia and hypophosphatemic myopathy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223441     DOI: 10.1016/0002-9343(79)90097-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Tumour induced hypophosphataemia associated with small cell carcinoma of the bronchus.

Authors:  J Banks; M D Penney; E G Anderson
Journal:  Thorax       Date:  1987-11       Impact factor: 9.139

Review 2.  Clinical disorders of phosphorus metabolism.

Authors:  G C Yu; D B Lee
Journal:  West J Med       Date:  1987-11

3.  Bone scan and red blood cell scan in a patient with epidermal naevus syndrome.

Authors:  W Becker; N Stosiek; K P Peters; F Wolf
Journal:  Eur J Nucl Med       Date:  1990

4.  Oncogenic osteomalacia.

Authors:  J McClure; P S Smith
Journal:  J Clin Pathol       Date:  1987-04       Impact factor: 3.411

5.  A small cell bronchogenic carcinoma associated with tumoral hypophosphataemia and inappropriate antidiuresis.

Authors:  N Robin; G Gill; C van Heyningen; W Fraser
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.